NP
Nuvectis Pharma Inc
🇺🇸XNAS.NVCTUnited StatesHealthcare
$22.23USDdown -1.12 (-4.8%)OpenEnd of day5:45 PM
Price$22.23-1.12 (-4.8%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US67080T1088
- CUSIP
- 67080T108
Company
- Employees
- 16
- Headquarters
- Fort Lee, United States
- Website
- https://www.nuvectis.com
- CEO
- Mr. Ron Bentsur M.B.A.
Market
- Shares outstanding
- 32.6M
- Market cap
- $725.68M
Key dates
- Next earnings
- Nov 3, 2026
Highlights
- Market cap
- $725.68M
- EPS LTM
- -$0.85calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -26.06calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $0-100%down year on year
- Net income
- -$27.85M-26.19%down year on year
- Gross margin
- Not reported
- Free cash flow
- -$19.51M-57.21%down year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.